London Stock Exchange · GSK
GSK plc price
Price history, key statistics, and comparable assets for GSK plc.
£19.61
+1.24% (£0.2400)
Historical prices
Price history
Intraday through long-term closing prices. Choose 1 day, 1 week, 1 month, 6 months, year to date, 1 year, 5 years, or all available history.
Point-in-time fields
Key statistics
- Previous close
- £19.37
- Open
- £19.31
- Day range
- £19.31 to £19.71
- 52-week range
- £12.89 to £22.82
- Volume
- 4.45m
- Average volume
- 8.02m
- Market cap
- 78.56bn
- P/E ratio (TTM)
- 16.62
Profile
About GSK plc
GSK plc trades on London Stock Exchange under GSK and is grouped under Health Technology. Figures marked unavailable are not estimated.
Editorial profile
GSK plc overview
GSK plc researches, develops, manufactures, and supplies vaccines and specialty and general medicines. Its portfolio addresses infectious diseases, HIV, respiratory and immunology conditions, oncology, and other therapeutic needs. These activities place the company in Health Technology and connect GSK to the specific products, services, customers, and operating assets described in its official materials.
SourcesGSK plcGSK is the ordinary share quoted on London Stock Exchange. GSK plc's investor materials publish annual and interim results, with other updates as scheduled. This profile refers to that local security and operating group, which matters when an issuer has several venues, share classes, depositary receipts, or a name that resembles another company.
SourcesGSK plcGSK plcA genuinely distinguishing feature is that GSK combines one of the industry's broad vaccine portfolios with ViiV Healthcare's dedicated HIV medicines business. The current GSK is a focused biopharma company following the separation of its former consumer-health business as Haleon. This is more precise than a broad sector label: it identifies a named platform, product architecture, network, asset base, or corporate structure that separates GSK plc from otherwise similar issuers.
SourcesGSK plc- Security type
- Ordinary Share
Primary sources
- GSK plc official company profileGSK plc · Retrieved 2026-08-10
- GSK plc investor relationsGSK plc · Retrieved 2026-08-10
- GSK listing informationGSK plc · Retrieved 2026-08-10
Contextual peers
Related assets
Same sector: Health Technology
Same market: United Kingdom
GSK questions
GSK plc questions
What business does GSK represent?
GSK represents GSK plc, which researches, develops, manufactures, and supplies vaccines and specialty and general medicines. Its portfolio addresses infectious diseases, HIV, respiratory and immunology conditions, oncology, and other therapeutic needs.
Which products, services, or operating markets are specifically associated with GSK?
Its portfolio addresses infectious diseases, HIV, respiratory and immunology conditions, oncology, and other therapeutic needs.
What specifically distinguishes the business behind GSK?
For GSK plc, the asset-specific distinction is that GSK combines one of the industry's broad vaccine portfolios with ViiV Healthcare's dedicated HIV medicines business. The current GSK is a focused biopharma company following the separation of its former consumer-health business as Haleon.
Risk and data disclosure
Read before using this data
Glide provides this market data for informational purposes only. It is not investment advice, a recommendation, or an offer to buy or sell any asset. Prices may be delayed or incomplete. Verify market data and consider your objectives, financial situation, and professional advice before acting.